PharmaCyte Biotech, Inc.
PMCB • NASDAQ
PharmaCyte Biotech, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joshua N. Silverman, with a market cap of $7.6M.
CEOJoshua N. Silverman
Next Earnings
No upcoming earnings scheduled for PharmaCyte Biotech, Inc.
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for PharmaCyte Biotech, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q3 2026 | -$0.17 | — | - | — | — |
| Dec 18, 2025 | Q2 2026 | -$1.24 | — | - | — |  10-Q |
| Sep 15, 2025 | Q1 2026 | -$1.23 | — | - | — | 10-Q |
| Aug 11, 2025 | Q4 2025 | $1.54 | — | - | — | 10-K |
| Mar 17, 2025 | Q3 2025 | -$0.44 | — | - | — | 10-Q |
| Dec 13, 2024 | Q2 2025 | -$0.39 | — | - | — | 10-Q |
| Sep 17, 2024 | Q1 2025 | $1.90 | — | - | — | 10-Q |
| Aug 13, 2024 | Q4 2024 | -$0.33 | — | - | — | 10-K |
| Mar 18, 2024 | Q3 2024 | -$0.65 | — | - | — | 10-Q |
| Dec 15, 2023 | Q2 2024 | -$0.26 | — | - | — | — |
| Sep 18, 2023 | Q1 2024 | -$0.28 | — | - | — | 10-Q |
| Jul 31, 2023 | Q4 2023 | -$0.05 | — | - | — | 10-K |